Jan Czyzyk

442 total citations
24 papers, 335 citations indexed

About

Jan Czyzyk is a scholar working on Immunology, Molecular Biology and Surgery. According to data from OpenAlex, Jan Czyzyk has authored 24 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 8 papers in Molecular Biology and 7 papers in Surgery. Recurrent topics in Jan Czyzyk's work include T-cell and B-cell Immunology (6 papers), Pancreatic function and diabetes (6 papers) and Renal Diseases and Glomerulopathies (4 papers). Jan Czyzyk is often cited by papers focused on T-cell and B-cell Immunology (6 papers), Pancreatic function and diabetes (6 papers) and Renal Diseases and Glomerulopathies (4 papers). Jan Czyzyk collaborates with scholars based in United States, Australia and France. Jan Czyzyk's co-authors include Kim Bottomly, Philip Fernsten, Jun Guan, Thomas Ardito, Lonnette Diggs, Shinji Hatakeyama, Dominique Joly, Sik Lee, David Leitenberg and Shuta Ishibe and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Jan Czyzyk

23 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Czyzyk United States 11 132 113 90 58 45 24 335
Markus A. Loeven Netherlands 9 88 0.7× 132 1.2× 217 2.4× 21 0.4× 27 0.6× 12 386
Hanshi Xu China 12 36 0.3× 156 1.4× 88 1.0× 54 0.9× 20 0.4× 23 343
Aiysha Abid Pakistan 11 49 0.4× 183 1.6× 26 0.3× 33 0.6× 55 1.2× 34 352
Pilar Nozal Spain 13 189 1.4× 83 0.7× 309 3.4× 15 0.3× 40 0.9× 40 433
Monica Concardi Italy 8 48 0.4× 216 1.9× 73 0.8× 67 1.2× 45 1.0× 13 373
Jennifer Laskowski United States 13 168 1.3× 81 0.7× 276 3.1× 27 0.5× 8 0.2× 21 437
Shunhua Guo United States 12 67 0.5× 68 0.6× 179 2.0× 23 0.4× 17 0.4× 22 371
Anna Colpo Italy 11 17 0.1× 133 1.2× 59 0.7× 47 0.8× 18 0.4× 24 376
Federica Banterla Italy 5 218 1.7× 66 0.6× 320 3.6× 11 0.2× 23 0.5× 7 431
Willeke E.M. Schroeijers Netherlands 13 149 1.1× 65 0.6× 262 2.9× 20 0.3× 38 0.8× 15 409

Countries citing papers authored by Jan Czyzyk

Since Specialization
Citations

This map shows the geographic impact of Jan Czyzyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Czyzyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Czyzyk more than expected).

Fields of papers citing papers by Jan Czyzyk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Czyzyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Czyzyk. The network helps show where Jan Czyzyk may publish in the future.

Co-authorship network of co-authors of Jan Czyzyk

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Czyzyk. A scholar is included among the top collaborators of Jan Czyzyk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Czyzyk. Jan Czyzyk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Karam, Sabine, et al.. (2024). Case report: Successful treatment of renal-limited thrombotic microangiopathy secondary to chronic lymphocytic leukemia. SHILAP Revista de lepidopterología. 4. 1400027–1400027.
2.
Czyzyk, Jan, et al.. (2022). The Role of Proteases and Serpin Protease Inhibitors in β-Cell Biology and Diabetes. Biomolecules. 12(1). 67–67. 15 indexed citations
3.
Czyzyk, Jan, et al.. (2021). SerpinB13 antibodies promote β cell development and resistance to type 1 diabetes. Science Translational Medicine. 13(588). 5 indexed citations
4.
Hanna, Christian, Loren P. Herrera Hernandez, Lihong Bu, et al.. (2021). IgA nephropathy presenting as macroscopic hematuria in 2 pediatric patients after receiving the Pfizer COVID-19 vaccine. Kidney International. 100(3). 705–706. 46 indexed citations
6.
Dugbartey, George J., Lingfeng Luo, Deanne Mickelsen, et al.. (2019). The Protective Role of Natriuretic Peptide Receptor 2 against High Salt Injury in the Renal Papilla. American Journal Of Pathology. 189(9). 1721–1731. 2 indexed citations
7.
Guo, Bing, Qing Lyu, Orazio J. Slivano, et al.. (2017). Serum Response Factor Is Essential for Maintenance of Podocyte Structure and Function. Journal of the American Society of Nephrology. 29(2). 416–422. 13 indexed citations
9.
Jha, Mithilesh Kumar, et al.. (2012). Anti-serpin Antibody-mediated Regulation of Proteases in Autoimmune Diabetes. Journal of Biological Chemistry. 288(3). 1612–1619. 8 indexed citations
10.
Czyzyk, Jan, Octavian Henegariu, Paula Preston‐Hurlburt, et al.. (2012). Enhanced Anti-Serpin Antibody Activity Inhibits Autoimmune Inflammation in Type 1 Diabetes. The Journal of Immunology. 188(12). 6319–6327. 8 indexed citations
11.
Szepietowska, Barbara, Wanling Zhu, Jan Czyzyk, Tore Eid, & Robert S. Sherwin. (2012). EphA5-EphrinA5 Interactions Within the Ventromedial Hypothalamus Influence Counterregulatory Hormone Release and Local Glutamine/Glutamate Balance During Hypoglycemia. Diabetes. 62(4). 1282–1288. 10 indexed citations
12.
Ma, Hong, Akashi Togawa, K. Soda, et al.. (2010). Inhibition of Podocyte FAK Protects against Proteinuria and Foot Process Effacement. Journal of the American Society of Nephrology. 21(7). 1145–1156. 106 indexed citations
13.
Czyzyk, Jan, Hui‐Chen Chen, Kim Bottomly, & Richard A. Flavell. (2008). p21 Ras/Impedes Mitogenic Signal Propagation Regulates Cytokine Production and Migration in CD4 T Cells. Journal of Biological Chemistry. 283(34). 23004–23015. 12 indexed citations
14.
Carrithers, Michael D., Lisette M. Carrithers, Jan Czyzyk, & Octavian Henegariu. (2007). Characterization of a severe parenchymal phenotype of experimental autoimmune encephalomyelitis in (C57BL6xB10.PL)F1 mice. Journal of Neuroimmunology. 187(1-2). 31–43. 2 indexed citations
15.
Czyzyk, Jan. (2006). The Role of Toll-Like Receptors in the Pathogenesis of Renal Disease. Seminars in Nephrology. 26(2). 167–172. 1 indexed citations
16.
Czyzyk, Jan, Jennifer L. Brogdon, Abdallah Badou, et al.. (2003). Activation of CD4 T cells by Raf-independent effectors of Ras. Proceedings of the National Academy of Sciences. 100(10). 6003–6008. 17 indexed citations
17.
Czyzyk, Jan, Philip Fernsten, Teresa R. Brtva, Channing J. Der, & John B. Winfield. (1998). CD45 and Src-Related Protein Tyrosine Kinases Regulate the T Cell Response to Phorbol Esters. Biochemical and Biophysical Research Communications. 243(2). 444–450. 4 indexed citations
18.
Czyzyk, Jan, Philip Fernsten, Melody Shaw, & John B. Winfield. (1996). Cell‐type specificity of anti‐CD45 autoantibodies in systemic lupus erythematosus. Arthritis & Rheumatism. 39(4). 592–599. 12 indexed citations
19.
Fernsten, Philip, et al.. (1994). Carbohydrate specificity of IgM autoantibodies to CD45 in Systemic Lupus Erythematosus. Molecular Biology Reports. 20(2). 85–95. 5 indexed citations
20.
Winfield, J B, Philip Fernsten, Jan Czyzyk, Ena Wang, & John J. Marchalonis. (1994). Antibodies to CD45 and other cell membrane antigens in systemic lupus erythematosus. Springer Seminars in Immunopathology. 16(2-3). 201–10. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026